TidalSense

About:

TidalSense aims to create a paradigm shift in the practice of respiratory medicine, starting with earlier, accurate diagnosis.

Website: https://tidalsense.com

Twitter/X: tidalsense

Top Investors: Business Growth Fund, Foresight Group, SBRI Healthcare, Downing Ventures

Description:

Developer of AI-driven respiratory diagnostic and monitoring technologies. The company's technologies are built on a foundation of a novel sensor technology (N-Tidal) that is able to detect changes in lung function quickly and accurately. N-Tidal converts sensor data into (novel) respiratory biomarkers in near-real-time (minutes). Data is managed automatically and the device is 4G connected, handheld, portable and has high patient acceptability. Using these biomarkers, the company has built an affordable AI-driven diagnostic test for COPD which automates testing and interpretation in under 5 minutes (compared to the clinical standard 30 minutes).

Total Funding Amount:

10.3M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2013-04-23

Contact Email:

info(AT)tidalsense.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-05-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai